NeuroCME

This activity is expired and is no longer available for CME credit.

EXPERT VIDEOCME

ABCR Therapy

Author(s)/Faculty: Michael Racke, MD
Release Date: 8/15/2016Expiration Date: 8/14/2018
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
One of the most effective treatments for MS in terms of controlling aspects of the immune system is disease modifying drugs, or ABCR treatment. ABCR drugs for MS refer to the following medications: Avonex (Interferon-beta-1a), Betaseron (Interferon-beta-1b), Copaxone (glatiramer acetate) and Rebif (Interferon-beta-1a). This CME activity will discuss advantages and disadvantages of ABCR therapy.